This gene is a member of the ATPase family AAA-domain containing 3 gene family and mainly encodes mitochondrial protein participating in multiple biological processes, which has been observed to promote tumor progression by enhancing the ability of tumor migration and chemotherapy resistance.28–30 In fact, ATAD3A is an effective predictor of clinical outcomes of patients with TNBC (Fig. 2c; Supplementary information, Fig. S2c). The gene discussed is ATAD3A; the disease is neoplasm.